Left Atrial Geometry and Outcomes After Atrial Fibrillation Ablation
NCT ID: NCT02373982
Last Updated: 2017-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
417 participants
OBSERVATIONAL
2013-01-31
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Inclusion of consecutive patients undergoing AF ablation during 2013 in whom a 3D-imaging of the left atrium (Cardiac CT or MRA) was acquired prior to the procedure and when procedural/follow-up data was prospectively collected.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Recurrence Risk of Atrial Fibrillation After Cryoballoon Ablation
NCT05492760
Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation
NCT04544397
AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation
NCT03368781
Pulmonary Vein (PV) Imaging by Intracardiac Echography (ICE) After Ablation
NCT05781282
CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial
NCT03716934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In total, 9 centers will include consecutive patients who underwent AF ablation from january to december 2013 in whom a 3D-imaging of the left atrium (Cardiac CT or MRA) was acquired prior to the procedure and when procedural/follow-up data was prospectively collected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First AF ablation procedure
* Prior 3D-imaging of the left atrium (CT or MRA)
* Prospective collection procedural and outcome data
* Obtention of Informed Consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Germans Trias i Pujol Hospital
OTHER
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER
Hospital del Mar
OTHER
Hospital Virgen de la Salud
OTHER
Hospital San Carlos, Madrid
OTHER
Fundación para la Investigación del Hospital Clínico de Valencia
OTHER
Complejo Hospitalario Universitario de Vigo
OTHER
Puerta de Hierro University Hospital
OTHER
Hospital Clinic of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Josep Lluis Mont Girbau
MD, PhD, FESC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Felipe Bisbal, MD
Role: PRINCIPAL_INVESTIGATOR
Germans Trias i Pujol Hospital
Lluís Mont, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain
Hospital de Sant Pau
Barcelona, Barcelona, Spain
Hospital del Mar
Barcelona, Barcelona, Spain
Hospital Clinic
Barcelona, , Spain
Hospital Clinico San Carlos
Madrid, , Spain
Hospital Puerta de Hierro
Madrid, , Spain
Hospital Virgen de la Salud
Toledo, , Spain
Hospital Clinico de Valencia
Valencia, , Spain
Complexo Hospitalario de Vigo
Vigo, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bisbal F, Guiu E, Calvo N, Marin D, Berruezo A, Arbelo E, Ortiz-Perez J, de Caralt TM, Tolosana JM, Borras R, Sitges M, Brugada J, Mont L. Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2013 Jul;24(7):752-9. doi: 10.1111/jce.12116. Epub 2013 Mar 14.
Bisbal F, Guiu E, Cabanas P, Calvo N, Berruezo A, Tolosana JM, Arbelo E, Vidal B, de Caralt TM, Sitges M, Brugada J, Mont L. Reversal of spherical remodelling of the left atrium after pulmonary vein isolation: incidence and predictors. Europace. 2014 Jun;16(6):840-7. doi: 10.1093/europace/eut385. Epub 2014 Jan 2.
Steinberg BA, Piccini JP. Left atrial remodeling: shape before size? J Cardiovasc Electrophysiol. 2013 Jul;24(7):760-1. doi: 10.1111/jce.12132. Epub 2013 Apr 9. No abstract available.
Bisbal F, Alarcon F, Ferrero-de-Loma-Osorio A, Gonzalez-Ferrer JJ, Alonso C, Pachon M, Tizon H, Cabanas-Grandio P, Sanchez M, Benito E, Teis A, Ruiz-Granell R, Perez-Villacastin J, Vinolas X, Arias MA, Valles E, Garcia-Campo E, Fernandez-Lozano I, Villuendas R, Mont L. Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study. Eur Heart J Cardiovasc Imaging. 2018 Sep 1;19(9):1002-1009. doi: 10.1093/ehjci/jey060.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LAGO-FA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.